JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M310166200 on September 25, 2003

J. Biol. Chem., Vol. 278, Issue 49, 48794-48804, December 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/49/48794    most recent
M310166200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohama, T.
Right arrow Articles by Karaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohama, T.
Right arrow Articles by Karaki, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Chronic Treatment with Interleukin-1{beta} Attenuates Contractions by Decreasing the Activities of CPI-17 and MYPT-1 in Intestinal Smooth Muscle*

Takashi Ohama, Masatoshi Hori, Koichi Sato{ddagger}, Hiroshi Ozaki§, and Hideaki Karaki

From the Department of Veterinary Pharmacology and {ddagger}Radioisotope Center, Graduate School of Agriculture and Life Sciences, the University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan

Interleukin-1{beta} (IL-1{beta}) is a proinflammatory cytokine that plays a central role in inflammatory bowel disease (IBD). In order to elucidate the mechanism of motility disorders frequently observed in IBD, we investigated the long term effects of IL-1{beta} on rat ileal smooth muscle contractility by using an organ culture system. When ileal smooth muscle strips were cultured with IL-1{beta} (10 ng/ml), contractions elicited by high K+ and carbachol were inhibited in a time-dependent manner. IL-1{beta} more strongly inhibited the carbachol-induced contractions than high K+ with decreasing myosin light chain phosphorylation. In the {alpha}-toxin-permeabilized ileal muscle, carbachol with GTP or guanosine 5'-3-O-(thio)triphosphate increased the Ca2+ sensitivity of contractile elements, and this G protein-coupled Ca2+ sensitization was significantly reduced in the IL-1{beta}-treated ileum. Among the functional proteins involved in the smooth muscle Ca2+ sensitization, CPI-17 expression was significantly reduced after the culture with IL-1{beta}, whereas the expressions of RhoA, ROCK-I, ROCK-II, MYPT-1, myosin light chain kinase, and myosin phosphatase (PP1) were unchanged. The phosphorylation level of CPI-17 by carbachol was low in accordance with the decrease in CPI-17 expression due to IL-1{beta} treatment. In contrast, constitutively phosphorylated MYPT-1 was also decreased in the IL-1{beta}-treated muscles. These results suggest that long term treatment with IL-1{beta} decreases either CPI-17 expression or MYPT-1 phosphorylation, which may result in an increase in myosin phosphatase activity to reduce force generation. Based on these findings, we consider IL-1{beta} to be an important mediator of gastrointestinal motility disorders in IBD, and CPI-17 and MYPT-1 are key molecules in the decreased smooth muscle contractility due to IL-1{beta}.


Received for publication, September 12, 2003

* This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences, The Yakult Foundation, Morinaga Hoshi-kai, and a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, and Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, the University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan. Tel.: 81-3-5841-5393; Fax: 81-3-58411-8183.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Mizuno, E. Isotani, J. Huang, H. Ding, J. T. Stull, and K. E. Kamm
Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C358 - C364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy
Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Ohama, M. Hori, E. Momotani, M. Elorza, W. T. Gerthoffer, and H. Ozaki
IL-1beta inhibits intestinal smooth muscle proliferation in an organ culture system: involvement of COX-2 and iNOS induction in muscularis resident macrophages
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1315 - G1322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Ohama, M. Hori, E. Momotani, Y. Iwakura, F. Guo, H. Kishi, S. Kobayashi, and H. Ozaki
Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-{alpha} and causes motility disorders
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1429 - G1438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong
Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong
RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Kim, S. Y. Cho, I. S. Han, S. D. Koh, and B. A. Perrino
CaM kinase II and phospholamban contribute to caffeine-induced relaxation of murine gastric fundus smooth muscle
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1202 - C1210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. H. Ratz, K. M. Berg, N. H. Urban, and A. S. Miner
Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C769 - C783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bonnevier and A. Arner
Actions Downstream of Cyclic GMP/Protein Kinase G Can Reverse Protein Kinase C-mediated Phosphorylation of CPI-17 and Ca2+Sensitization in Smooth Muscle
J. Biol. Chem., July 9, 2004; 279(28): 28998 - 29003.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.